Factors Associated With Dose Escalation of Fesoterodine for Treatment of Overactive Bladder in People >65 Years of Age: A Post Hoc Analysis of Data From the SOFIA Study

Neurourology and Urodynamics - United States

doi 10.1002/nau.23814